Longer Term Follow-up of a Multicenter, Phase 2 Study of Ibrutinib Plus Fludarabine, Cyclophosphamide, Rituximab (ifcr) As Initial Therapy for Younger Patients with Chronic Lymphocytic LeukemiaMatthew S. Davids,Danielle M. Brander,Svitlana Tyekucheva,Chinheng Chen,James Kaminski,Josie Montegaard,Alvaro J. Alencar,Mohammad Omaira,Caron Jacobson,Philippe Armand,Samuel Y. Ng,Jennifer L. Crombie,Ann S. LaCasce,Jon E. Arnason,Ephraim Hochberg,Ronald W. Takvorian,Jeremy S. Abramson,David C. Fisher,Jennifer R. BrownBlood(2021)引用 3|浏览33AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要